PhoreMost appoints Professor Peter Parker and Dr Jason Imbriglio to Scientific Advisory Board 17th July 2023
PhoreMost Reaches Milestone in a Target Discovery Alliance with Boehringer Ingelheim 5th January 2023
PhoreMost enters multi-target collaboration with targeted protein degradation leader Arvinas 28th October 2022